ICOSAPENT ETHYL
Generic: ICOSAPENT ETHYL
Qilu Pharmaceutical Co.Manufacturer
ORALRoute
ICOSAPENT ETHYLActive Substance
2024-11-20Original Approval
ICOSAPENT ETHYL is FDA application ANDA218899, sponsored by QILU. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-05-30
Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza,Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules.
Class II2026-03-09
Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., IndiaFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized
Top Reported Reactions
1
DRUG INEFFECTIVE
114 reports
2
OFF LABEL USE
107 reports
3
DIARRHOEA
75 reports
4
CONDITION AGGRAVATED
63 reports
5
NAUSEA
60 reports
6
MATERNAL EXPOSURE DURING PREGNANCY
53 reports
7
FATIGUE
46 reports
8
OVERLAP SYNDROME
46 reports
9
PNEUMONIA
39 reports
10
DECREASED APPETITE
37 reports